Sharp Edge Labs

Sharp Edge Labs

Biotechnology, 2403 Sidney St, Pittsburgh, Pennsylvania, 15203, United States, 1-10 Employees

sharptx.com

  • LinkedIn

Who is SHARP EDGE LABS

Imagine a world where genetic diseases are treated with orally-available small molecule drugs. That's the future Sharp Edge Labs is building. Sharp Edge is a preclinical-stage life scienc...

Read More

map
  • 2403 Sidney St, Pittsburgh, Pennsylvania, 15203, United States Headquarters: 2403 Sidney St, Pittsburgh, Pennsylvania, 15203, United States
  • 2010 Date Founded: 2010
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from SHARP EDGE LABS

Sharp Edge Labs Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Sharp Edge Labs

Answer: Sharp Edge Labs's headquarters are located at 2403 Sidney St, Pittsburgh, Pennsylvania, 15203, United States

Answer: Sharp Edge Labs's official website is https://sharptx.com

Answer: Sharp Edge Labs's revenue is Under $1 Million

Answer: Sharp Edge Labs's SIC: 8731

Answer: Sharp Edge Labs has 1-10 employees

Answer: Sharp Edge Labs is in Biotechnology

Answer: Sharp Edge Labs contact info: Phone number: Website: https://sharptx.com

Answer: Imagine a world where genetic diseases are treated with orally-available small molecule drugs. That's the future Sharp Edge Labs is building. Sharp Edge is a preclinical-stage life sciences company developing drugs for genetic diseases. Our monogenic disease focus de-risks the clinical path. Each pipeline program has a genetically identifiable subset of patients and an early Phase IB pharmacodynamic readout. We combine three core techologies to create a scalable platform for discovery and development. CoreX(tm) is s suite of assay technologies that enable the creation of realistic cellular models of genetic diseases. AlloChem(tm) is a proprietary compound library computationally biased to contain molecules that can bind proteins allosterically, stabilizing them, and restoring their function. Disco/Mine(tm) is a suite of computational and machine learning tools that enhances our experimental approach rather than replacing it. These combine to create a scalable platform with over 10 programs at various stages of development. The company has programs in Frontotemporal Dementia, and genetic subsets of Alzheimers and Parkinsons, as well as lysosomal storage disorders and other loss-of-function diseases. The team and its advisors includes ex and current Genzyme/Sanofi, Synageva, Pfizer and Shire executives.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access